Recurrent Myocardial Ischemic njury Is Significantly Attenuated by Pre-Emptive deno-Associated Virus Heme Oxygenase-1 Gene Delivery

OBJECTIVES We assessed the hypothesis that overexpression of the antioxidant enzyme heme oxygenase (HO)-1 may protect against chronic recurrent ischemia/reperfusion injury. BACKGROUND Multiple and recurring episodes of myocardial ischemia can result in significant myocardial damage, including myocyte death, fibrosis, and wall thinning, leading to impaired ventricular function and cardiac failure. METHODS In this study we used a closed-chest rodent model of chronic recurring myocardial ischemia and reperfusion to investigate the efficacy of pre-emptive gene therapy in overexpressing the antioxidant enzyme HO-1, using adeno-associated virus (AAV)-2 as the delivery vector. RESULTS We show that constitutive overexpression of HO-1 can prevent myocardial wall thinning, inflammation, fibrosis, and deterioration of cardiac function (as measured by echocardiography, histology, and immunohistochemistry) induced by repeated transient myocardial ischemia and reperfusion injury. With HO-1 therapy, there was a significant reduction in apoptosis as determined by levels of markers of survival proteins and terminal deoxynucleotidyltransferase dUTP nick end-labeling staining. This prevention of tissue damage was also associated with reduction in superoxide generation. CONCLUSIONS Taken together we provide the first evidence of the therapeutic efficacy of pre-emptive AAV–HO-1 delivery for prevention against multiple ischemic injury. This approach protects myocytes by simultaneously activating protective response and inhibiting pathological left ventricular remodeling and, therefore, may be a useful cardio-protective strategy for patients with coronary artery disease at a high risk for recurrent myocardial ischemia. (J Am Coll ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.038

[1]  L. Rozamus,et al.  Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. , 2005, Blood.

[2]  S. Solomon,et al.  Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Barja-Fidalgo,et al.  Heme Inhibits Human Neutrophil Apoptosis: Involvement of Phosphoinositide 3-Kinase, MAPK, and NF-κB , 2004, The Journal of Immunology.

[4]  M. Layne,et al.  Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival , 2004, Gene Therapy.

[5]  L. Becker.  New concepts in reactive oxygen species and cardiovascular reperfusion physiology. , 2004, Cardiovascular research.

[6]  M. Loda,et al.  Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus. , 2004, Biochemical and biophysical research communications.

[7]  J. Crapo,et al.  Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Gardner,et al.  Viral Gene Transfer of the Antiapoptotic Factor Bcl-2 Protects Against Chronic Postischemic Heart Failure , 2002, Circulation.

[9]  J. Oyama,et al.  Gene Therapy Strategy for Long-Term Myocardial Protection Using Adeno-Associated Virus-Mediated Delivery of Heme Oxygenase Gene , 2002, Circulation.

[10]  R. Gibson,et al.  A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. , 2001, Human gene therapy.

[11]  M. Amrani,et al.  Heat Shock Protein 70 Gene Transfection Protects Mitochondrial and Ventricular Function Against Ischemia-Reperfusion Injury , 2001, Circulation.

[12]  J. Ingwall,et al.  Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice , 2001, Circulation research.

[13]  J. Alam,et al.  Hmox-1 Constitutes an Adaptive Response to Effect Antioxidant Cardioprotection: A Study With Transgenic Mice Heterozygous for Targeted Disruption of the Heme Oxygenase-1 Gene , 2001, Circulation.

[14]  M. Hess,et al.  Gene Transfer of Heat-Shock Protein 70 Reduces Infarct Size In Vivo After Ischemia/Reperfusion in the Rabbit Heart , 2001, Circulation.

[15]  R. Nagai,et al.  Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. , 2000, Biochemical and biophysical research communications.

[16]  A. Choi,et al.  Heme oxygenase: colors of defense against cellular stress. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[17]  R. Samulski,et al.  Adeno-associated virus vectors for gene therapy: more pros than cons? , 2000, Molecular medicine today.

[18]  G Baumgarten,et al.  A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. , 2000, American journal of physiology. Heart and circulatory physiology.

[19]  A. Choi,et al.  Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.

[20]  Alan McClelland,et al.  Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector , 2000, Nature Genetics.

[21]  P. Sarathchandra,et al.  Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. , 2000, American journal of physiology. Heart and circulatory physiology.

[22]  S. Ylä-Herttuala,et al.  Cardiovascular gene therapy , 2000, The Lancet.

[23]  J. Downward.  How BAD phosphorylation is good for survival , 1999, Nature Cell Biology.

[24]  L. Kobzik,et al.  Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. , 1999, The Journal of clinical investigation.

[25]  B. Davidson,et al.  Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. , 1998, Circulation research.

[26]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[27]  L. Leinwand,et al.  Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. , 1997, Circulation.

[28]  T. Flotte,et al.  Adeno-associated virus vectors for gene therapy. , 1995, Gene therapy.

[29]  A. Kitabatake,et al.  Time Course of Functional Improvement in Stunned Myocardium in Risk Area in Patients With Reperfused Anterior Infarction , 1993, Circulation.